GPR35 Polyclonal Antibody

    • Catalog No.:YT2015
    • Applications:WB;IF;ELISA
    • Reactivity:Human;Rat;Mouse;
      • Target:
      • GPR35
      • Fields:
      • >>Neuroactive ligand-receptor interaction
      • Gene Name:
      • GPR35
      • Protein Name:
      • G-protein coupled receptor 35
      • Human Gene Id:
      • 2859
      • Human Swiss Prot No:
      • Q9HC97
      • Mouse Swiss Prot No:
      • Q9ES90
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human GPR35. AA range:51-100
      • Specificity:
      • GPR35 Polyclonal Antibody detects endogenous levels of GPR35 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IF 1:200 - 1:1000. ELISA: 1:20000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • GPR35;G-protein coupled receptor 35;Kynurenic acid receptor;KYNA receptor
      • Observed Band(KD):
      • 34kD
      • Background:
      • function:Orphan receptor.,similarity:Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Expressed in all adult and fetal tissues examined, including pancreatic islets and skeletal muscle, with relatively higher levels in adult lung, small intestine, colon and stomach.,
      • Function:
      • function:Orphan receptor.,similarity:Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Expressed in all adult and fetal tissues examined, including pancreatic islets and skeletal muscle, with relatively higher levels in adult lung, small intestine, colon and stomach.,
      • Subcellular Location:
      • Cell membrane ; Multi-pass membrane protein . Internalized to the cytoplasm after exposure to kynurenic acid.
      • Expression:
      • Predominantly expressed in immune and gastrointestinal tissues.
      • Products Images
      • Immunofluorescence analysis of A549 cells, using GPR35 Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from LOVO cells, using GPR35 Antibody. The lane on the right is blocked with the synthesized peptide.
      • Lysophosphatidylcholine (17:0) Improves HFD-Induced Hyperglycemia & Insulin Resistance: A Mechanistic Mice Model Study